<DOC>
	<DOC>NCT00143156</DOC>
	<brief_summary>To evaluate the efficacy and safety of pregabalin administered twice a day compared to placebo in reducing pain in subjects with painful diabetic peripheral neuropathy.</brief_summary>
	<brief_title>Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Males or females at least 18 years of age, of any ethnic origin Type 1 or 2 diabetes mellitus Pain score greater than or equal to 4 on the 11point numeric pain rating scale Neurologic disorders unrelated to diabetic neuropathy that may confuse or confound the assessment of neuropathic pain. Presence of severe pain associated with conditions other than diabetic peripheral neuropathy, that could confound the assessment or selfevaluation of pain due to DPN.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>